NCT04865419 - Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 11, 2021

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions

Haematological Malignancies

Interventions

DRUG

AZD0466

AZD0466 powder for concentrate for solution for infusion will be administered by IV infusion.

DRUG

Voriconazole

Voriconazole film-coated tablet will be administered orally.

Trial Locations (15)

3004

Research Site, Melbourne

3050

Research Site, Parkville

20089

Research Site, Rozzano

24105

Research Site, Kiel

32224

Research Site, Jacksonville

33604

Research Site, Pessac

40138

Research Site, Bologna

43210

Research Site, Columbus

47014

Research Site, Meldola

47392

Research Site, Busan

52074

Research Site, Aachen

60611

Research Site, Chicago

69120

Research Site, Heidelberg

77030

Research Site, Houston

91010

Research Site, Duarte